Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04141969 · ClinicalTrials.gov registry record · Phase 2
A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome
A Phase 2 study, sponsored by Optimal Health Research.
- Completed
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
NCT04141969 is a Phase 2 study that has completed, run by Optimal Health Research. The registered enrollment target is 100 participants.
The verdict
NCT04141969, a Phase 2 study, has completed, sponsored by Optimal Health Research.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study will determine the effectiveness of a nutraceutical in treating the lingering effects of Lyme Disease after antibiotic treatment.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT RLP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-11-29 |
| Est. Completion | 2021-03-28 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04141969
The ClinicalTrials.gov registry entry for NCT04141969 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Optimal Health Research, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04141969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04141969 about?
NCT04141969 is a clinical study titled "A Novel Nutraceutical to Combat Post-Lyme Disease Syndrome". This study will determine the effectiveness of a nutraceutical in treating the lingering effects of Lyme Disease after antibiotic treatment.
What is the current status of trial NCT04141969?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2019-11-29. Estimated completion is 2021-03-28.
What interventions are being tested in trial NCT04141969?
The interventions under investigation include: Placebo (OTHER), RLP (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04141969?
This trial is sponsored by Optimal Health Research, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.